Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea

BACKGROUND: Multiple inhaler triple therapy (MITT), comprising inhaled corticosteroids (ICS), long-acting beta-agonists (LABA), and long-acting muscarinic antagonists (LAMA), has been used as an escalation treatment for patients with chronic obstructive pulmonary disease (COPD). However, real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chang-Hoon, Kim, Mi-Sook, Yeo, See-Hwee, Rhee, Chin-Kook, Park, Heung-Woo, Yang, Bo-Ram, Lee, Joongyub, Cho, Eun-Yeong, Xu, Xiaomeng, Navarro Rojas, Aldo Amador, Shantakumar, Sumitra, Milea, Dominique, Choi, Nam-Kyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446529/
https://www.ncbi.nlm.nih.gov/pubmed/36064539
http://dx.doi.org/10.1186/s12931-022-02136-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446529/
https://www.ncbi.nlm.nih.gov/pubmed/36064539
http://dx.doi.org/10.1186/s12931-022-02136-0

Ejemplares similares